Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SAN RAMON, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology...
-
EWING, N.J., March 29, 2016 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced the approval by the U.S. Food and Drug Administration (FDA) of three new dosage strengths of...
-
MIDVALE, Utah, March 29, 2016 (GLOBE NEWSWIRE) -- Sportsman’s Warehouse (NASDAQ:SPWH) is expanding its operations to include a new retail location in Rohnert Park, California. The grand...
-
DALLAS, March 29, 2016 (GLOBE NEWSWIRE) -- Blue Calypso, Inc. (OTCQB:BCYP), an innovator of mobile consumer activation, engagement and social advocacy solutions for manufacturers and...
-
PETAH TIKVA, Israel, March 29, 2016 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ:GILT) (TASE:GILT), a worldwide leader in satellite networking technology, solutions and services,...
-
SAN FRANCISCO, March 29, 2016 (GLOBE NEWSWIRE) -- Boyden, a global leader in executive search, today released a new issue of its Leadership Series, featuring an in-depth interview with Bill Ingham,...
-
LONDON, March 29, 2016 (GLOBE NEWSWIRE) -- Union Bank UK PLC, a wholly owned subsidiary of the Union Bank of Nigeria PLC, needed better visibility into the different types of sensitive data its...
-
DALLAS, March 28, 2016 (GLOBE NEWSWIRE) -- Associa Cares, the non-profit family assistance organization of Associa, was invited to the North Texas Tollway Authority's (NTTA) monthly board meeting in...
-
MALVERN, Pa., March 28, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical stage specialty pharmaceutical company, today announced that it has entered into an agreement...
-
CORALVILLE, Iowa, March 28, 2016 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH) announced today that its Investigational New Drug (IND) application for KP511, KemPharm’s prodrug of...